RxDoctor Payments Data

Carlos Arroyo

Podiatrist · San Juan, PRNPI 1487837704

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.3%), education and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Acumed LLC at 30.5% of the total. Reporting peaked in 2022 at $1,905 and has fallen 96.0% since, to $76 in 2024.

$4,996in general payments, 2019–2025

Across 27 payments — averaging $185.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acumed LLC$2K
  • Arthrex$2K
  • Orthofix Medical, Inc.$694
  • Arteriocyte Medical Systems, Inc.$334
  • Integra Lifesciences Corporation$271
  • Stryker$187
  • plus $466 from 5 others

What the payments were for

  • Travel & lodging$2,06341%
  • Food & beverage$1,44129%
  • Education$1,49230%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few podiatrist providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$42,751
Medicare patients
206
Services billed
590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl825$7,869
Clindamycin Hcl281$5,040
Diclofenac Sodium ErDiclofenac Sodium172$4,747
Moxifloxacin Hcl28$1,786
Halobetasol Propionate27$1,688
Acetaminophen-CodeineAcetaminophen With Codeine129$1,363
Itraconazole17$1,129
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav50$1,031
Levofloxacin78$1,027
Ciclopirox21$835
Diclofenac Sodium11$295
Gabapentin35$224
Pregabalin16$202
Midazolam Hcl68$180
Fentanyl CitrateFentanyl Citrate/Pf50$174

Paid to pharmacies, not to this prescriber.

Other podiatrist in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →